S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
66,000% upside on tiny biotech? (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
66,000% upside on tiny biotech? (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
66,000% upside on tiny biotech? (Ad)
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
66,000% upside on tiny biotech? (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
66,000% upside on tiny biotech? (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
66,000% upside on tiny biotech? (Ad)
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
66,000% upside on tiny biotech? (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
66,000% upside on tiny biotech? (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
66,000% upside on tiny biotech? (Ad)
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
66,000% upside on tiny biotech? (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
66,000% upside on tiny biotech? (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
66,000% upside on tiny biotech? (Ad)
A coal mine fire in southern China's Guizhou province kills 16 people
NASDAQ:VIVO

Meridian Bioscience (VIVO) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$33.93
▼
$34.02
50-Day Range
$33.00
▼
$33.97
52-Week Range
$20.35
▼
$34.38
Volume
6.42 million shs
Average Volume
973,737 shs
Market Capitalization
$1.50 billion
P/E Ratio
35.02
Dividend Yield
N/A
Price Target
N/A
ProfileAnalyst RatingsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

VIVO stock logo

About Meridian Bioscience (NASDAQ:VIVO) Stock

Meridian Bioscience, Inc. engages in the development, production, sale, and distribution of diagnostic products. Its platforms include molecular, immunoassay, urea breath, and blood chemistry. It operates through the Diagnostics and Life Science segments. The Diagnostics segment consists of manufacturing operations for infectious disease and blood chemistry products and the sale and distribution of diagnostics products domestically and abroad. The Life Science segment distributes bulk antigens, antibodies, polymerase chain reaction/ quantitative PCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers, agri-bio companies, and other diagnostic manufacturing companies. The company was founded by William J. Motto in 1976 and is headquartered in Cincinnati, OH.


VIVO Stock News Headlines

July 25, 2023 | finance.yahoo.com
Meridian Bioscience Continues Expansion of H. pylori Diagnostic Testing Solutions with FDA Clearance of Premier HpSA Flex
May 17, 2023 | marketwatch.com
Rapid Testing Kits Market Size Opportunities, Top Countries Data, Future Trends and Share Forecast 2028
September 24, 2023 | Legacy Research (Ad)
WARNING: Mandatory U.S. Dollar Recall is Weeks Away
If you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.
April 27, 2023 | marketwatch.com
Rapid Testing Kits Market Size with Growth Opportunities, Top Countries Data, Future Trends and Share with Revenue Forecast 2028
April 19, 2023 | thestreet.com
Meridian Bioscience Stock To Go Ex-dividend Tomorrow (VIVO)
April 19, 2023 | markets.businessinsider.com
Meridian Bioscience Announces FDA Clearance for Innovative Curian® Shiga Toxin Assay
April 6, 2023 | bizjournals.com
Former executives at Meridian Bioscience subsidiary facing federal charges
April 5, 2023 | markets.businessinsider.com
Meridian Bioscience Comments on DOJ Announcement Regarding Former Executives of Magellan Diagnostics
September 24, 2023 | Legacy Research (Ad)
WARNING: Mandatory U.S. Dollar Recall is Weeks Away
If you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.
March 30, 2023 | thestreet.com
Meridian Bioscience Stock Hits New 52-Week Low (VIVO)
March 26, 2023 | thestreet.com
Meridian Bioscience Stock Hits New 52-Week High (VIVO)
March 23, 2023 | usnews.com
Phoenix Union Bioscience High School
March 20, 2023 | marketwatch.com
Global "Diagnostics PCR Market" 2023: On-going Trends and Growth Insights by 2027
February 1, 2023 | finanznachrichten.de
Meridian Bioscience, Inc.: SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience
February 1, 2023 | finance.yahoo.com
Meridian Bioscience finalizes $1.53B sale to South Korean-based firms
January 31, 2023 | finance.yahoo.com
SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience
December 29, 2022 | benzinga.com
Meridian Bioscience's Return On Capital Employed Overview
December 13, 2022 | seekingalpha.com
Meridian Biosciences: Why I Moved On But May Go Back In
December 12, 2022 | finance.yahoo.com
Meridian Bioscience Announces Anticipated Closing Date of the Pending Merger
December 12, 2022 | finance.yahoo.com
Meridian Bioscience sets closing date for $1.53 billion deal
November 22, 2022 | seekingalpha.com
Meridian Bioscience Non-GAAP EPS of $0.21, revenue of $65.67M
November 22, 2022 | finance.yahoo.com
Meridian Bioscience (VIVO) Q4 Earnings Surpass Estimates
November 17, 2022 | finance.yahoo.com
BellRing Brands (BRBR) Beats Q4 Earnings Estimates
October 15, 2022 | uk.finance.yahoo.com
Meridian Bioscience, Inc. (VIVO)
September 28, 2022 | msn.com
Vivo X Fold Plus launched: Check price, specifications and other details
September 20, 2022 | seekingalpha.com
VIVO Meridian Bioscience, Inc.
September 15, 2022 | apnews.com
INVESTIGATION ALERT: Halper Sadeh LLC Investigates VIVO, OCSL, AVLR
See More Headlines
Receive VIVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Meridian Bioscience and its competitors with MarketBeat's FREE daily newsletter.

VIVO Company Calendar

Last Earnings
11/12/2021
Today
9/24/2023
Fiscal Year End
9/30/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Diagnostic substances
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:VIVO
CUSIP
58958410
CIK
794172
Web
www.meridianbioscience.com
Phone
(513) 271-3700
Fax
513-271-3762
Employees
702
Year Founded
1977

Profitability

EPS (Most Recent Fiscal Year)
$0.97
Trailing P/E Ratio
35.02
Forward P/E Ratio
40.93
P/E Growth
N/A
Net Income
$42.46 million
Net Margins
12.70%
Pretax Margin
16.31%
Return on Equity
16.74%
Return on Assets
13.09%

Debt

Debt-to-Equity Ratio
0.07
Current Ratio
3.63
Quick Ratio
2.46

Sales & Book Value

Annual Sales
$333.02 million
Price / Sales
4.49
Cash Flow
$1.78 per share
Price / Cash Flow
19.13
Book Value
$8.41 per share
Price / Book
4.04

Miscellaneous

Outstanding Shares
44,010,000
Free Float
42,996,000
Market Cap
$1.50 billion
Optionable
Optionable
Beta
0.23

Social Links

7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • John Patrick Kenny
    Chief Executive Officer & Executive Director
  • Andrew S. KitzmillerAndrew S. Kitzmiller
    Chief Financial Officer & Executive Vice President
  • Julie Smith
    Chief Accounting Officer, Senior VP & Controller
  • Emerson C. Moser
    Senior Vice President & General Counsel
  • Lourdes WeltzienLourdes Weltzien
    Executive Vice President-Life Science

Key Competitors

View All Competitors













VIVO Stock - Frequently Asked Questions

Should I buy or sell Meridian Bioscience stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Meridian Bioscience in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" VIVO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in VIVO, but not buy additional shares or sell existing shares.
View VIVO analyst ratings or view top-rated stocks.

How were Meridian Bioscience's earnings last quarter?

Meridian Bioscience, Inc. (NASDAQ:VIVO) issued its quarterly earnings data on Friday, November, 12th. The company reported $0.24 EPS for the quarter, topping analysts' consensus estimates of $0.21 by $0.03. The company had revenue of $76.20 million for the quarter, compared to analysts' expectations of $68.40 million. Meridian Bioscience had a net margin of 12.70% and a trailing twelve-month return on equity of 16.74%. During the same period in the previous year, the company posted $0.19 earnings per share.

What is Jack Kenny's approval rating as Meridian Bioscience's CEO?

7 employees have rated Meridian Bioscience Chief Executive Officer Jack Kenny on Glassdoor.com. Jack Kenny has an approval rating of 56% among the company's employees. This puts Jack Kenny in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Meridian Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Meridian Bioscience investors own include AbbVie (ABBV), NVIDIA (NVDA), Advanced Micro Devices (AMD), Micron Technology (MU), Pfizer (PFE), AT&T (T), Gilead Sciences (GILD), Amgen (AMGN), Alibaba Group (BABA) and Tesla (TSLA).

What is Meridian Bioscience's stock symbol?

Meridian Bioscience trades on the NASDAQ under the ticker symbol "VIVO."

What is Meridian Bioscience's stock price today?

One share of VIVO stock can currently be purchased for approximately $33.97.

How much money does Meridian Bioscience make?

Meridian Bioscience (NASDAQ:VIVO) has a market capitalization of $1.50 billion and generates $333.02 million in revenue each year. The company earns $42.46 million in net income (profit) each year or $0.97 on an earnings per share basis.

How many employees does Meridian Bioscience have?

The company employs 702 workers across the globe.

Does Meridian Bioscience have any subsidiaries?
The following companies are subsidiares of Meridian Bioscience: Exalenz Bioscience.
Read More
How can I contact Meridian Bioscience?

Meridian Bioscience's mailing address is 3471 RIVER HILLS DRIVE, CINCINNATI OH, 45244. The official website for the company is www.meridianbioscience.com. The company can be reached via phone at (513) 271-3700, via email at mbi@meridianbioscience.com, or via fax at 513-271-3762.

This page (NASDAQ:VIVO) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -